Insight Molecular Diagnostics (IMDX) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $3.06, +9.68% vs the prior close of $2.79.
- Volume 177.70K shares, 0.7x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
IMDX jumps 9.7% to $3.06. Closed at $3.06, +9.68% vs the prior close of $2.79. Day range $2.79–$3.12, opened at $2.81.
IMDX daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — IMDX jumps 9.7% to $3.06
- Closed at $3.06, +9.68% vs the prior close of $2.79. Day range $2.79–$3.12, opened at $2.81.
- Volume was 177.70K shares, 0.7x its 50-day average of 258.26K.
- Price is -22.2% vs its 50-day average ($3.93) and -38.4% vs its 200-day average ($4.97).
- 52-week range $2.42–$8.51; today's close sits at 11% of that range, 64.0% below the 52-week high.
Oct 14, 2026 — IMDX slides 6.7% to $2.79, a 6-month low, 3 down days in a row
- Closed at $2.79, -6.69% vs the prior close of $2.99. Day range $2.75–$3.10, opened at $2.98.
- Volume was 407.50K shares, 1.6x its 50-day average of 254.12K.
- Price is -29.8% vs its 50-day average ($3.97) and -44.1% vs its 200-day average ($4.99).
- 52-week range $2.42–$8.51; today's close sits at 6% of that range, 67.2% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — IMDX slides 5.7% to $2.99, a 6-month low
- Closed at $2.99, -5.68% vs the prior close of $3.17. Day range $2.94–$3.20, opened at $3.16.
- Volume was 313.00K shares, 1.2x its 50-day average of 253.72K.
- Price is -25.6% vs its 50-day average ($4.02) and -40.3% vs its 200-day average ($5.01).
- 52-week range $2.42–$8.51; today's close sits at 9% of that range, 64.9% below the 52-week high.
Oct 12, 2026 — IMDX slides 5.9% to $3.17, a 3-month low
- Closed at $3.17, -5.93% vs the prior close of $3.37. Day range $3.13–$3.37, opened at $3.35.
- Volume was 219.30K shares, 0.9x its 50-day average of 250.57K.
- Price is -21.9% vs its 50-day average ($4.06) and -36.9% vs its 200-day average ($5.02).
- 52-week range $2.42–$8.51; today's close sits at 12% of that range, 62.7% below the 52-week high.
Oct 9, 2026 — IMDX rises 2.7% to $3.37
- Closed at $3.37, +2.74% vs the prior close of $3.28. Day range $3.19–$3.44, opened at $3.29.
- Volume was 156.40K shares, 0.6x its 50-day average of 249.35K.
- Price is -17.6% vs its 50-day average ($4.09) and -33.0% vs its 200-day average ($5.03).
- 52-week range $2.42–$8.51; today's close sits at 16% of that range, 60.4% below the 52-week high.
Oct 8, 2026 — IMDX slides 5.2% to $3.28
- Closed at $3.28, -5.20% vs the prior close of $3.46. Day range $3.08–$3.56, opened at $3.44.
- Volume was 227.30K shares, 0.9x its 50-day average of 247.30K.
- Price is -20.3% vs its 50-day average ($4.11) and -34.9% vs its 200-day average ($5.04).
- 52-week range $2.42–$8.51; today's close sits at 14% of that range, 61.5% below the 52-week high.
Oct 7, 2026 — IMDX rises 2.4% to $3.46
- Closed at $3.46, +2.37% vs the prior close of $3.38. Day range $3.26–$3.66, opened at $3.35.
- Volume was 153.90K shares, 0.6x its 50-day average of 246.79K.
- Price is -16.4% vs its 50-day average ($4.14) and -31.5% vs its 200-day average ($5.05).
- 52-week range $2.42–$8.51; today's close sits at 17% of that range, 59.3% below the 52-week high.
Oct 6, 2026 — IMDX slides 7.9% to $3.38 on 1.9x normal volume
- Closed at $3.38, -7.90% vs the prior close of $3.67. Day range $3.19–$3.76, opened at $3.73.
- Volume was 460.10K shares, 1.9x its 50-day average of 238.73K — unusually heavy trading.
- Price is -18.7% vs its 50-day average ($4.16) and -33.2% vs its 200-day average ($5.06).
- 52-week range $2.42–$8.51; today's close sits at 16% of that range, 60.3% below the 52-week high.
Oct 5, 2026 — IMDX jumps 6.7% to $3.67
- Closed at $3.67, +6.69% vs the prior close of $3.44. Day range $3.17–$3.74, opened at $3.44.
- Volume was 408.40K shares, 1.8x its 50-day average of 232.05K.
- Price is -12.3% vs its 50-day average ($4.19) and -27.6% vs its 200-day average ($5.07).
- 52-week range $2.42–$8.51; today's close sits at 21% of that range, 56.9% below the 52-week high.
Oct 2, 2026 — IMDX dips 0.9% to $3.44
- Closed at $3.44, -0.86% vs the prior close of $3.47. Day range $3.36–$3.60, opened at $3.49.
- Volume was 403.00K shares, 1.8x its 50-day average of 226.62K.
- Price is -18.2% vs its 50-day average ($4.21) and -32.2% vs its 200-day average ($5.08).
- 52-week range $2.42–$8.51; today's close sits at 17% of that range, 59.6% below the 52-week high.
IMDX latest news & SEC filings
Every SEC filing by or about IMDX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 21, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Aug 10, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $239.00K (prior year $518.00K) (-53.9% vs Jun 30, 2025)
- Net income: -$11.26M (prior year -$9.74M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.31 (prior year -$0.30) (loss widened vs Jun 30, 2025)
Aug 10, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 24, 2026 · S-8 — Registration of shares for employee stock plans (S-8)
Registration of shares for employee stock plans (S-8)
Jul 6, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 6, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 6, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade IMDX
- Last results release: Aug 10, 2026 (8-K Item 2.02). Previous ones: May 13, 2026, Mar 26, 2026, Nov 10, 2025. Based on that rhythm, the next report is likely around Nov 9, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 5.03% (largest 18.9%). That is a volatile stock.
- Liquidity: about 328.76K shares (≈$1.01M) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $3.06 vs a range of $2.42–$8.51 (11% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 25 open-market buys, 0 sales; latest: Partners, L.P. Broadwood bought 250,923 shares on Apr 27, 2026.
- Latest filings: 8-K Sep 21, 2026; 10-Q Aug 10, 2026; 8-K Aug 10, 2026.
- Share count: 32.72M shares outstanding (Aug 3, 2026), +14.3% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: In Vitro & In Vivo Diagnostic Substances.
IMDX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 2.81 | 3.12 | 2.79 | 3.06 | 177.70K |
| Oct 14, 2026 | 2.98 | 3.10 | 2.75 | 2.79 | 407.50K |
| Oct 13, 2026 | 3.16 | 3.20 | 2.94 | 2.99 | 313.00K |
| Oct 12, 2026 | 3.35 | 3.37 | 3.13 | 3.17 | 219.30K |
| Oct 9, 2026 | 3.29 | 3.44 | 3.19 | 3.37 | 156.40K |
| Oct 8, 2026 | 3.44 | 3.56 | 3.08 | 3.28 | 227.30K |
| Oct 7, 2026 | 3.35 | 3.66 | 3.26 | 3.46 | 153.90K |
| Oct 6, 2026 | 3.73 | 3.76 | 3.19 | 3.38 | 460.10K |
| Oct 5, 2026 | 3.44 | 3.74 | 3.17 | 3.67 | 408.40K |
| Oct 2, 2026 | 3.49 | 3.60 | 3.36 | 3.44 | 403.00K |
| Oct 1, 2026 | 3.57 | 3.62 | 3.24 | 3.47 | 394.60K |
| Sep 30, 2026 | 3.40 | 3.66 | 3.31 | 3.59 | 287.10K |
| Sep 29, 2026 | 3.23 | 3.51 | 3.07 | 3.38 | 311.20K |
| Sep 28, 2026 | 3.82 | 3.99 | 3.15 | 3.18 | 590.50K |
| Sep 25, 2026 | 3.99 | 4.00 | 3.76 | 3.92 | 313.50K |
| Sep 24, 2026 | 3.88 | 4.00 | 3.70 | 3.95 | 274.30K |
| Sep 23, 2026 | 4.08 | 4.08 | 3.65 | 3.91 | 597.30K |
| Sep 22, 2026 | 4.04 | 4.26 | 4.03 | 4.14 | 308.70K |
| Sep 21, 2026 | 4.09 | 4.13 | 3.84 | 4.01 | 253.50K |
| Sep 18, 2026 | 3.90 | 4.10 | 3.77 | 4.00 | 317.90K |
About Insight Molecular Diagnostics
Insight Molecular Diagnostics (IMDX) is listed on the Nasdaq and classified by the SEC under “In Vitro & In Vivo Diagnostic Substances”. Its business address is in NASHVILLE, TN. State of incorporation: CA. Fiscal year ends December 31. SEC CIK 1642380.
IMDX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Andrew Arno | Director | Jul 6, 2026 |
| Andrew J. Last | Director | Jul 6, 2026 |
| Josh Riggs | CEO and President | Mar 30, 2026 |
| Lou Silverman | Director | Jul 6, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Andrea S. James | Chief Financial Officer | Mar 30, 2026 |
| James Yang Liu | VP ACCT, Cntlr, Treasurer, PAO | Mar 30, 2026 |
| Josh Riggs | CEO and President | Mar 30, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Apr 27, 2026 | Partners, L.P. Broadwood | Buy | 250,923 | $3.64 |
| Apr 27, 2026 | Partners, L.P. Broadwood | Buy | 0 | — |
| Apr 27, 2026 | Capital Inc Broadwood | Buy | 250,923 | $3.64 |
| Apr 27, 2026 | Capital Inc Broadwood | Buy | 0 | — |
| Apr 27, 2026 | Neal C Bradsher | Buy | 250,923 | $3.64 |
| Apr 27, 2026 | Neal C Bradsher | Buy | 0 | — |
| Apr 24, 2026 | Partners, L.P. Broadwood | Buy | 0 | — |
| Apr 24, 2026 | Partners, L.P. Broadwood | Buy | 38,880 | $3.53 |
| Apr 24, 2026 | Capital Inc Broadwood | Buy | 0 | — |
| Apr 24, 2026 | Capital Inc Broadwood | Buy | 38,880 | $3.53 |
| Apr 24, 2026 | Neal C Bradsher | Buy | 0 | — |
| Apr 24, 2026 | Neal C Bradsher | Buy | 38,880 | $3.53 |
| Apr 23, 2026 | Partners, L.P. Broadwood | Buy | 0 | — |
| Apr 23, 2026 | Partners, L.P. Broadwood | Buy | 280,381 | $3.50 |
| Apr 23, 2026 | Capital Inc Broadwood | Buy | 0 | — |
IMDX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $4.05M | $-50.22M | -1.65 | $-22.18M |
| Dec 31, 2024 | $1.88M | $-60.66M | -4.66 | $-20.69M |
| Dec 31, 2023 | $1.50M | $-27.78M | -3.75 | $-23.32M |
| Dec 31, 2022 | $958.00K | $-72.90M | -13.25 | $-45.57M |
| Dec 31, 2021 | $2.20M | $-64.10M | — | $-35.94M |
Latest balance sheet: total assets $29.44M, total liabilities $50.74M, cash $17.76M (as of Jun 30, 2026).
IMDX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 10, 2026 | 8-K Item 2.02 (results) | $4.77 |
| May 13, 2026 | 8-K Item 2.02 (results) | $5.10 |
| Mar 26, 2026 | 8-K Item 2.02 (results) | $4.11 |
| Nov 10, 2025 | 8-K Item 2.02 (results) | $6.80 |
| Aug 11, 2025 | 8-K Item 2.02 (results) | $2.61 |
| May 12, 2025 | 8-K Item 2.02 (results) | $2.81 |
| Mar 24, 2025 | 8-K Item 2.02 (results) | $3.33 |
| Nov 12, 2024 | 8-K Item 2.02 (results) | $3.00 |
| Aug 8, 2024 | 8-K Item 2.02 (results) | — |
| May 15, 2024 | 8-K Item 2.02 (results) | — |
| Apr 12, 2024 | 8-K Item 2.02 (results) | — |
| Nov 9, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · In Vitro & In Vivo Diagnostic Substances
Idexx Laboratories (IDXX)Lantheus (LNTH)Intellia Therapeutics (NTLA)Neogen (NEOG)Celldex Therapeutics (CLDX)QuidelOrtho (QDEL)Achieve Life Sciences (ACHV)Myriad Genetics (MYGN)Alpha Teknova (TKNO)Volitionrx (VNRX)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on IMDX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.